at its recommended dosage of 200 mg 3 times daily , or alternatively 400 mg once daily as a sustained-release preparation , it produces substantial reductions in plasma triglyceride and cholesterol concentrations in patients with hypertriglyceridaemia and hypercholesterolaemia , respectively .
C0008377
cholesterol
C0020443
hypercholesterolaemia